MarketPulse

oncology

23 articles
BenzingaBenzinga··Vandana Singh

Gilead to Acquire Arcellx for $7.8B to Expand CAR-T Oncology Portfolio

Gilead acquires Arcellx for $7.8B to gain CAR-T therapy anito-cel for multiple myeloma, with FDA approval expected by late 2026.
GILDACLXacquisitionFDA approval
BenzingaBenzinga··Globe Newswire

Coherus Oncology Raises $50.1M in Stock Offering to Fund Oncology Pipeline

Coherus Oncology raised $50.1M through stock offering to fund commercial launch of LOQTORZI and advance its oncology pipeline development.
CHRSclinical developmentpublic offering
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Coherus Oncology Raises $50.1M Through Common Stock Offering

Coherus Oncology raises $50.1M via stock offering to fund commercial expansion of LOQTORZI and advance oncology pipeline development programs.
CHRSclinical developmentpublic offering